Appili Therapeutics Inc. announced that it has appointed Prakash Gowd, MBA, BSc. Pharm, C.Dir., to its Board of Directors. Mr. Gowd's career covers a broad range of commercial successes involving corporate development, fundraising, and marketing across multiple business models and therapeutic areas.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.035 CAD | 0.00% | 0.00% | 0.00% |
Apr. 26 | Appili Therapeutics Inc. announced that it has received CAD 0.3 million in funding | CI |
Apr. 02 | Appili Therapeutics To be Acquired by Aditxt, Inc. | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 3.12M | |
+7.83% | 115B | |
+12.91% | 107B | |
-13.29% | 22.31B | |
-3.99% | 21.6B | |
-6.63% | 18.23B | |
-39.93% | 17.62B | |
+6.88% | 14.26B | |
+32.86% | 12.37B | |
-28.25% | 8.28B |
- Stock Market
- Equities
- APLI Stock
- News Appili Therapeutics Inc.
- Appili Therapeutics Inc. Appoints Prakash Gowd to its Board of Directors